Imunon, Inc. (IMNN)
0.9003
-0.01
(-0.74%)
USD |
NASDAQ |
Nov 05, 16:00
Imunon Net Income (TTM) : -14.72M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.72M |
| March 31, 2026 | -14.64M |
| December 31, 2025 | -14.50M |
| September 30, 2025 | -14.33M |
| June 30, 2025 | -15.75M |
| March 31, 2025 | -17.79M |
| December 31, 2024 | -18.62M |
| September 30, 2024 | -19.45M |
| June 30, 2024 | -18.08M |
| March 31, 2024 | -18.85M |
| December 31, 2023 | -19.52M |
| September 30, 2023 | -27.86M |
| June 30, 2023 | -30.53M |
| March 31, 2023 | -31.02M |
| December 31, 2022 | -35.90M |
| September 30, 2022 | -26.89M |
| June 30, 2022 | -26.15M |
| March 31, 2022 | -25.55M |
| December 31, 2021 | -20.77M |
| September 30, 2021 | -19.56M |
| June 30, 2021 | -22.22M |
| March 31, 2021 | -22.12M |
| December 31, 2020 | -21.48M |
| September 30, 2020 | -21.57M |
| June 30, 2020 | -18.98M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.54M |
| December 31, 2019 | -16.85M |
| September 30, 2019 | -8.268M |
| June 30, 2019 | -7.448M |
| March 31, 2019 | -9.774M |
| December 31, 2018 | -11.88M |
| September 30, 2018 | -22.04M |
| June 30, 2018 | -23.06M |
| March 31, 2018 | -20.06M |
| December 31, 2017 | -20.75M |
| September 30, 2017 | -21.46M |
| June 30, 2017 | -22.20M |
| March 31, 2017 | -21.50M |
| December 31, 2016 | -22.05M |
| September 30, 2016 | -22.17M |
| June 30, 2016 | -20.03M |
| March 31, 2016 | -21.17M |
| December 31, 2015 | -22.46M |
| September 30, 2015 | -23.40M |
| June 30, 2015 | -26.08M |
| March 31, 2015 | -27.08M |
| December 31, 2014 | -25.49M |
| September 30, 2014 | -22.99M |
| June 30, 2014 | -20.12M |
| March 31, 2014 | -13.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 9.391B |
| Anika Therapeutics, Inc. | -3.121M |
| BioCryst Pharmaceuticals, Inc. | -359.66M |
| Curis, Inc. | -21.15M |